Antilymphocyte Serum
"Antilymphocyte Serum" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Serum containing GAMMA-GLOBULINS which are antibodies for lymphocyte ANTIGENS. It is used both as a test for HISTOCOMPATIBILITY and therapeutically in TRANSPLANTATION.
Descriptor ID |
D000961
|
MeSH Number(s) |
A12.207.152.846.500.203 D12.776.124.486.485.114.573.203 D12.776.124.790.651.114.573.203 D12.776.377.715.548.114.573.203 D20.215.401.203
|
Concept/Terms |
Antilymphocyte Serum- Antilymphocyte Serum
- Antilymphocyte Serums
- Serum, Antilymphocyte
- Serums, Antilymphocyte
Antilymphocyte Globulin- Antilymphocyte Globulin
- Antilymphocyte Globulins
- Globulin, Antilymphocyte
- Globulins, Antilymphocyte
Antithymoglobulin- Antithymoglobulin
- Antithymoglobulins
- Antithymocyte Globulin
- Antithymocyte Globulins
- Globulin, Antithymocyte
- Globulins, Antithymocyte
- Lymphocyte Immune Globulin, Anti-Thymocyte Globulin
- Lymphocyte Immune Globulin, Anti Thymocyte Globulin
- Anti-Thymocyte Globulin
- Anti Thymocyte Globulin
- Anti-Thymocyte Globulins
- Globulin, Anti-Thymocyte
- Globulins, Anti-Thymocyte
Antilymphoblast Globulins- Antilymphoblast Globulins
- Antilymphoblast Globulin
- Globulin, Antilymphoblast
- Globulins, Antilymphoblast
Antilymphocyte Immunoglobulin- Antilymphocyte Immunoglobulin
- Antilymphocyte Immunoglobulins
- Immunoglobulin, Antilymphocyte
- Immunoglobulins, Antilymphocyte
|
Below are MeSH descriptors whose meaning is more general than "Antilymphocyte Serum".
Below are MeSH descriptors whose meaning is more specific than "Antilymphocyte Serum".
This graph shows the total number of publications written about "Antilymphocyte Serum" by people in this website by year, and whether "Antilymphocyte Serum" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1980 | 1 | 1 | 2 | 1981 | 1 | 1 | 2 | 1982 | 0 | 2 | 2 | 1983 | 0 | 1 | 1 | 1984 | 0 | 1 | 1 | 1987 | 0 | 2 | 2 | 1988 | 0 | 1 | 1 | 1989 | 0 | 2 | 2 | 1990 | 0 | 1 | 1 | 1992 | 0 | 1 | 1 | 1993 | 0 | 1 | 1 | 1994 | 0 | 1 | 1 | 1995 | 1 | 2 | 3 | 1996 | 2 | 2 | 4 | 1997 | 3 | 4 | 7 | 1998 | 0 | 1 | 1 | 1999 | 0 | 1 | 1 | 2001 | 4 | 0 | 4 | 2003 | 2 | 1 | 3 | 2004 | 0 | 1 | 1 | 2005 | 2 | 4 | 6 | 2006 | 2 | 0 | 2 | 2009 | 0 | 1 | 1 | 2015 | 1 | 0 | 1 | 2017 | 1 | 0 | 1 | 2020 | 1 | 0 | 1 | 2021 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Antilymphocyte Serum" by people in Profiles.
-
Orfali N, Zhang MJ, Allbee-Johnson M, Boelens JJ, Artz AS, Brunstein CG, McNiece IK, Milano F, Abid MB, Chee L, Diaz MA, Grunwald MR, Hematti P, Hsu J, Lazarus HM, Munshi PN, Prestidge T, Ringden O, Rizzieri D, Riches ML, Seo S, Solh M, Solomon S, Szwajcer D, Yared J, van Besien K, Eapen M. Planned Granulocyte Colony-Stimulating Factor Adversely Impacts Survival after Allogeneic Hematopoietic Cell Transplantation Performed with Thymoglobulin for Myeloid Malignancy. Transplant Cell Ther. 2021 12; 27(12):993.e1-993.e8.
-
Nair A, Coromina Hernandez L, Shah S, Zervos X, Zimmerman M, Sasaki K, Diago T, Hashimoto K, Fujiki M, Aucejo F, Bollinger J, Kaiser TL, Miller CM, Quintini C, Fung JJ, Eghtesad B. Induction Therapy With Antithymocyte Globulin and Delayed Calcineurin Inhibitor Initiation for Renal Protection in Liver Transplantation: A Multicenter Randomized Controlled Phase II-B Trial. Transplantation. 2022 05 01; 106(5):997-1003.
-
Schinstock CA, Mannon RB, Budde K, Chong AS, Haas M, Knechtle S, Lefaucheur C, Montgomery RA, Nickerson P, Tullius SG, Ahn C, Askar M, Crespo M, Chadban SJ, Feng S, Jordan SC, Man K, Mengel M, Morris RE, O'Doherty I, Ozdemir BH, Seron D, Tambur AR, Tanabe K, Taupin JL, O'Connell PJ. Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group. Transplantation. 2020 05; 104(5):911-922.
-
Gooptu M, Kim HT, Chen YB, Rybka W, Artz A, Boyer M, Johnston L, McGuirk J, Shea TC, Jagasia M, Shaughnessy PJ, Reynolds CG, Fields M, Alyea EP, Ho VT, Glavin F, Dipersio JF, Westervelt P, Ritz J, Soiffer RJ. Effect of Antihuman T Lymphocyte Globulin on Immune Recovery after Myeloablative Allogeneic Stem Cell Transplantation with Matched Unrelated Donors: Analysis of Immune Reconstitution in a Double-Blind Randomized Controlled Trial. Biol Blood Marrow Transplant. 2018 11; 24(11):2216-2223.
-
Soiffer RJ, Kim HT, McGuirk J, Horwitz ME, Johnston L, Patnaik MM, Rybka W, Artz A, Porter DL, Shea TC, Boyer MW, Maziarz RT, Shaughnessy PJ, Gergis U, Safah H, Reshef R, DiPersio JF, Stiff PJ, Vusirikala M, Szer J, Holter J, Levine JD, Martin PJ, Pidala JA, Lewis ID, Ho VT, Alyea EP, Ritz J, Glavin F, Westervelt P, Jagasia MH, Chen YB. Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation. J Clin Oncol. 2017 Dec 20; 35(36):4003-4011.
-
Echenique IA, Angarone MP, Gordon RA, Rich J, Anderson AS, McGee EC, Abicht TO, Kang J, Stosor V. Invasive fungal infection after heart transplantation: A 7-year, single-center experience. Transpl Infect Dis. 2017 Feb; 19(1).
-
Segovia J, van Besien K. Antithymocyte globulin for graft-versus-host disease prophylaxis: mistakenly maligned. Leuk Lymphoma. 2015 Apr; 56(4):841-2.
-
Lyons P, Castillo J, Potter L, Fedson S. Serum sickness after treatment with rabbit antithymocyte globulin in a heart transplant recipient with previous rabbit exposure. Transplant Proc. 2015 Jan-Feb; 47(1):198-200.
-
Thrush PT, Gossett JG, Costello JM, Matthews KL, Nubani R, Bhagat H, Backer CL, Pahl E. Role for immune monitoring to tailor induction prophylaxis in pediatric heart recipients. Pediatr Transplant. 2014 Feb; 18(1):79-86.
-
Manitpisitkul W, Wilson N, Cooper M, Gurk-Turner C, Hurley H, Rasetto F, KuKuruga D, Barth RN, Philosophe B. Rescue therapy for early antibody mediated rejection with a proteasome inhibitor: a case report. Clin Transpl. 2009; 461-3.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|